IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

LUBRANO DI SCORPANIELLO, Ennio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.128
EU - Europa 10.888
AS - Asia 4.012
SA - Sud America 1.202
AF - Africa 547
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 17
Totale 30.822
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.885
RU - Federazione Russa 4.924
IE - Irlanda 1.963
SG - Singapore 1.849
BR - Brasile 921
CN - Cina 791
IT - Italia 596
FR - Francia 580
UA - Ucraina 548
DE - Germania 475
FI - Finlandia 458
AT - Austria 374
CI - Costa d'Avorio 357
VN - Vietnam 337
SE - Svezia 333
GB - Regno Unito 319
HK - Hong Kong 195
IN - India 189
CA - Canada 120
AR - Argentina 92
BD - Bangladesh 92
MX - Messico 72
IQ - Iraq 70
TR - Turchia 68
JP - Giappone 65
ZA - Sudafrica 65
NL - Olanda 59
PL - Polonia 58
EC - Ecuador 44
CO - Colombia 43
ES - Italia 42
ID - Indonesia 42
PK - Pakistan 41
BE - Belgio 40
VE - Venezuela 37
SA - Arabia Saudita 32
LT - Lituania 27
MA - Marocco 26
AU - Australia 22
PH - Filippine 22
AZ - Azerbaigian 20
CL - Cile 20
UZ - Uzbekistan 20
IR - Iran 19
IL - Israele 18
TN - Tunisia 18
EG - Egitto 17
KZ - Kazakistan 16
JO - Giordania 15
BO - Bolivia 14
EU - Europa 14
KR - Corea 14
DZ - Algeria 13
KE - Kenya 12
MY - Malesia 12
RO - Romania 12
PE - Perù 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
NP - Nepal 10
PY - Paraguay 10
UY - Uruguay 10
CZ - Repubblica Ceca 9
HR - Croazia 9
PA - Panama 9
CH - Svizzera 8
KG - Kirghizistan 8
OM - Oman 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
AL - Albania 7
ET - Etiopia 7
PT - Portogallo 7
SN - Senegal 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
GE - Georgia 6
GR - Grecia 6
LB - Libano 5
LK - Sri Lanka 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
AO - Angola 4
CR - Costa Rica 4
KW - Kuwait 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
CY - Cipro 3
DK - Danimarca 3
GT - Guatemala 3
HU - Ungheria 3
NO - Norvegia 3
XK - ???statistics.table.value.countryCode.XK??? 3
GI - Gibilterra 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MD - Moldavia 2
NG - Nigeria 2
Totale 30.783
Salva come PNG Salva come JPEG
Città #
Dallas 4.374
Dublin 1.963
Moscow 1.655
Jacksonville 1.323
San Jose 1.268
Chandler 1.133
Singapore 1.021
Ashburn 550
The Dalles 434
Wilmington 409
Vienna 366
Abidjan 357
Helsinki 314
Rome 277
Houston 261
San Mateo 248
Beijing 232
Lauterbourg 227
Hong Kong 193
Ann Arbor 185
Princeton 179
Los Angeles 162
Boardman 147
Woodbridge 146
Ho Chi Minh City 122
New York 113
Frankfurt am Main 112
Columbus 106
Council Bluffs 98
Dearborn 94
São Paulo 87
Santa Clara 68
Tokyo 61
Hanoi 60
Orem 60
Warsaw 47
Amsterdam 43
Chicago 41
Redwood City 41
Chennai 38
London 38
Brooklyn 37
Johannesburg 37
Rio de Janeiro 37
Mountain View 36
Brussels 35
Toronto 35
Molise 34
Montreal 34
Denver 33
San Francisco 32
Atlanta 28
Hillsboro 28
Manchester 28
Jinan 27
Mexico City 27
Dhaka 26
Milan 25
Nuremberg 25
Baghdad 24
Boston 20
Seattle 20
Baku 19
Nanjing 19
Shanghai 19
Shenyang 18
Tashkent 18
Falls Church 17
Guangzhou 17
Istanbul 17
Lahore 17
Phoenix 17
Caracas 16
Ottawa 16
Amman 14
Augusta 14
Mumbai 14
Ningbo 14
Stockholm 14
Auburn Hills 13
Jakarta 13
Leawood 13
Porto Alegre 13
Quito 13
Belo Horizonte 12
Fortaleza 12
Haikou 12
Naples 12
Paris 12
Poplar 12
Bogotá 11
Brasília 11
Campinas 11
Curitiba 11
Falkenstein 11
Guayaquil 11
Haiphong 11
La Paz 11
Nairobi 11
New Delhi 11
Totale 19.808
Salva come PNG Salva come JPEG
Nome #
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action 2.724
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 248
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 214
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 214
An overview of low disease activity and remission in psoriatic arthritis. 207
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 207
An audit of anthropometric measurements by medical and physiotherapy staff in patients with ankylosing spondylitis 204
ANTHROPOMETRIC MEASUREMENTS AND DISABILITY IN A OPEN FOLLOW UP STUDY ON ANKYLOSING SPONDYLITIS WITH COMBINED MEDICAL AND REHABILITATIVE TREATMENT 195
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 185
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 184
A novel biological target for the treatment of psoriatic arthritis. 183
Aortic involvement in ankylosing spondylitis 183
Antiphospholipid syndrome, activated protein C resistance and mutation C -> T 677 in the MTHFR gene with juvenile pulmonary embolism. A case report 183
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 181
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 181
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 178
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 177
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 173
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 173
A national survey on the management of psoriatic arthritis using the Delphi method 167
A rare enthesopathy in psoriatic oligoarthritis 167
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 165
Measuring psoriatic disease in clinical practice. An expert opinion position paper. 164
La spondilodiscite delle spondiloartriti sieronegative 164
Assessment of psoriatic nail disease activity by rheumatologists 163
Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis 162
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 162
Iperuricemia e rischio cardio-renale 156
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients 155
Venous thrombophilia in a patient with protein S deficiency, factor V Leiden and homozygous MTHFR C -> T677 mutation 154
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 154
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 154
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 153
Pharmacoeconomic issues in psoriatic arthritis 152
Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up 151
Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement 151
The arthritis of ulcerative colitis: clinical and genetic aspects 150
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 150
Simple clinical indicators for early psoriatic arthritis detection. 149
Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model 148
Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis? 146
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study 146
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 146
Somatic perception in irritable bowel syndrome (IBS) patients with and without fibromyalgia (FMS). Does the severity of IBS influence the perception of somatic stimuli? 145
Patient education in psoriatic arthritis: a cross sectional study on knowledge by a validated self-administered questionnaire 144
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 144
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? 143
An International Multidisciplinary Delphi-Based Consensus on Heat Therapy in Musculoskeletal Pain 140
The performance of CASPAR criteria in early psoriatic arthritis - preliminary results from an Italian prospective multicentric study 140
Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions 140
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 140
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 138
The role of IL-17 in the treatment of psoriatic arthritis 138
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 138
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 137
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 136
Consensus on the management of patients with psoriatic arthritis in a dermatology setting 136
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 135
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 135
Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation 135
Venous thrombophilia with severe mesenteric involvement associated to homozygosity for factor V Leiden and heterozygosity for G20210A mutation of prothrombin 135
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 135
Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies 135
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 134
Validity of the modified stoke ankylosing spondylitis spine score (M-SASSS) and of the bath ankylosing spondylitis radiology index (BASRI) for the radiological assessment of axial involvement in psoriatic arthritis. multicentre validation study. Part one. 134
The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire 134
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 134
Psoriatic arthritis: imaging techniques 132
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 132
Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis. 131
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 130
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. 130
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study 130
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept 130
Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis 128
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 128
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 128
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. 127
Trauma and seronegative spondylarthropathy 127
Physical trauma triggers psoriasis in a patient with undifferentiated seronegative spondyloarthropathy 127
Fibromyalgia is strongly associated with the severity of inflammatory bowel syndrome. 127
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: A systematic review. 127
Role of comorbidities in spondyloarthritis including psoriatic arthritis 127
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 127
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 126
Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome? 126
Updated guidelines for the management of axial disease in psoriatic arthritis 126
Unmet Needs in Axial Spondyloarthritis 126
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review 125
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. 125
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology 125
Secukinumab for ankylosing spondylitis and psoriatic arthritis 125
The effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria 125
Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study 125
An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis 124
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 124
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia 123
Treatment options: NSAIDs and DMARDs 123
Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey. 123
LA COMPLICANZA ARTICOLARE DELLA MALATTIA CELIACA. STUDIO SU 62 CASI: RISULTATI PRELIMINARI 123
Totale 17.410
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.953
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021334 0 0 0 0 0 0 0 0 0 17 266 51
2021/2022968 51 252 16 31 55 28 29 106 141 154 43 62
2022/20234.662 535 121 102 392 245 377 16 220 2.328 146 82 98
2023/2024855 238 133 55 21 30 72 18 47 19 47 84 91
2024/20253.476 460 120 432 92 544 143 60 258 306 114 431 516
2025/202616.129 455 1.664 3.317 926 3.192 2.686 1.600 581 596 1.112 0 0
Totale 31.308